Valle Franco
Related Filers (3)
Ownership (21)
4
Thursday, 1/18/2024
Biomea Fusion, Inc.: Statement of changes in beneficial ownership of securities
4
Friday, 12/1/2023
Biomea Fusion, Inc.: Statement of changes in beneficial ownership of securities
4
Friday, 6/2/2023
Biomea Fusion, Inc.: Statement of changes in beneficial ownership of securities
4
Tuesday, 1/10/2023
Biomea Fusion, Inc.: Statement of changes in beneficial ownership of securities
4
Friday, 12/2/2022
Biomea Fusion, Inc.: Statement of changes in beneficial ownership of securities
4
Monday, 11/14/2022
Biomea Fusion, Inc.: Statement of changes in beneficial ownership of securities
4
Wednesday, 6/1/2022
Biomea Fusion, Inc.: Statement of changes in beneficial ownership of securities
4
Tuesday, 1/18/2022
Biomea Fusion, Inc.: Statement of changes in beneficial ownership of securities
4
Tuesday, 12/7/2021
Biomea Fusion, Inc.: Statement of changes in beneficial ownership of securities
3
Thursday, 8/5/2021
Biomea Fusion, Inc.: Initial statement of beneficial ownership of securities
4
Thursday, 8/5/2021
Biomea Fusion, Inc.: Statement of changes in beneficial ownership of securities
4
Thursday, 1/28/2021
Eidos Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Wednesday, 1/13/2021
Eidos Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Tuesday, 11/10/2020
Eidos Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Friday, 10/9/2020
Eidos Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Friday, 6/5/2020
Eidos Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Wednesday, 4/22/2020
Eidos Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Monday, 3/30/2020
Eidos Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Wednesday, 3/4/2020
Eidos Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
3
Thursday, 1/9/2020
Eidos Therapeutics, Inc.: Initial statement of beneficial ownership of securities
3
Monday, 4/3/2017
Lion Biotechnologies, Inc.: Initial statement of beneficial ownership of securities